Richardson P - Search Results

1

Richardson P, Hideshima T, Anderson K. Richardson P, et al. Biomed Pharmacother. 2002 May;56(3):115-28. doi: 10.1016/s0753-3322(02)00168-3. Biomed Pharmacother. 2002. PMID: 12046682 Review.

2

Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.

Avigan D, Wu Z, Gong J, Joyce R, Levine J, Elias A, Richardson P, Milano J, Kennedy L, Anderson K, Kufe D. Avigan D, et al. Among authors: richardson p. Clin Cancer Res. 1999 Oct;5(10):2735-41. Clin Cancer Res. 1999. PMID: 10537336

3

Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy.

Hideshima T, Chauhan D, Shima Y, Raje N, Davies FE, Tai YT, Treon SP, Lin B, Schlossman RL, Richardson P, Muller G, Stirling DI, Anderson KC. Hideshima T, et al. Among authors: richardson p. Blood. 2000 Nov 1;96(9):2943-50. Blood. 2000. PMID: 11049970 Free article. Clinical Trial.

4

The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, Adams J, Anderson KC. Hideshima T, et al. Among authors: richardson p. Cancer Res. 2001 Apr 1;61(7):3071-6. Cancer Res. 2001. PMID: 11306489

5

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration.

Podar K, Tai YT, Davies FE, Lentzsch S, Sattler M, Hideshima T, Lin BK, Gupta D, Shima Y, Chauhan D, Mitsiades C, Raje N, Richardson P, Anderson KC. Podar K, et al. Among authors: richardson p. Blood. 2001 Jul 15;98(2):428-35. doi: 10.1182/blood.v98.2.428. Blood. 2001. PMID: 11435313 Free article.

6

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications.

Mitsiades CS, Treon SP, Mitsiades N, Shima Y, Richardson P, Schlossman R, Hideshima T, Anderson KC. Mitsiades CS, et al. Among authors: richardson p. Blood. 2001 Aug 1;98(3):795-804. doi: 10.1182/blood.v98.3.795. Blood. 2001. PMID: 11468181 Free article.

7

The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications.

Hideshima T, Chauhan D, Schlossman R, Richardson P, Anderson KC. Hideshima T, et al. Among authors: richardson p. Oncogene. 2001 Jul 27;20(33):4519-27. doi: 10.1038/sj.onc.1204623. Oncogene. 2001. PMID: 11494147

8

Novel therapies targeting the myeloma cell and its bone marrow microenvironment.

Hideshima T, Chauhan D, Podar K, Schlossman RL, Richardson P, Anderson KC. Hideshima T, et al. Among authors: richardson p. Semin Oncol. 2001 Dec;28(6):607-12. doi: 10.1016/s0093-7754(01)90033-8. Semin Oncol. 2001. PMID: 11740818 Review.

9

Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.

Gupta D, Treon SP, Shima Y, Hideshima T, Podar K, Tai YT, Lin B, Lentzsch S, Davies FE, Chauhan D, Schlossman RL, Richardson P, Ralph P, Wu L, Payvandi F, Muller G, Stirling DI, Anderson KC. Gupta D, et al. Among authors: richardson p. Leukemia. 2001 Dec;15(12):1950-61. doi: 10.1038/sj.leu.2402295. Leukemia. 2001. PMID: 11753617

10

Thalidomide: emerging role in cancer medicine.

Richardson P, Hideshima T, Anderson K. Richardson P, et al. Annu Rev Med. 2002;53:629-57. doi: 10.1146/annurev.med.53.082901.104043. Annu Rev Med. 2002. PMID: 11818493 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,392 results

Search Page

Filters